Richard Paulson
Board Member
Karyopharm Therapeutics Inc. (KPTI)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Karyopharm Therapeutics Inc. (KPTI) | President and Chief Executive Officer | $770,000 | $2,320,902 |
| 2024 | Karyopharm Therapeutics Inc. (KPTI) | President and Chief Executive Officer | $769,600 | $2,069,341 |
| 2023 | Karyopharm Therapeutics Inc. (KPTI) | President and Chief Executive Officer | $740,000 | $2,626,288 |
| 2022 | Karyopharm Therapeutics Inc. (KPTI) | President and Chief Executive Officer | $696,800 | $6,910,015 |
| 2021 | Karyopharm Therapeutics Inc. (KPTI) | President and Chief Executive Officer | $468,365 | $8,355,172 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.